A detailed history of Coston, Mc Isaac & Partners transactions in Eli Lilly & CO stock. As of the latest transaction made, Coston, Mc Isaac & Partners holds 517 shares of LLY stock, worth $411,361. This represents 0.15% of its overall portfolio holdings.

Number of Shares
517
Previous 516 0.19%
Holding current value
$411,361
Previous $467,000 1.93%
% of portfolio
0.15%
Previous 0.18%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$772.14 - $960.02 $772 - $960
1 Added 0.19%
517 $458,000
Q1 2024

Apr 17, 2024

BUY
$592.2 - $792.28 $592 - $792
1 Added 0.19%
516 $401,000
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $9,998 - $13,783
-23 Reduced 4.28%
515 $276,000
Q1 2023

Apr 19, 2023

BUY
$310.63 - $364.82 $48,768 - $57,276
157 Added 41.21%
538 $184,000
Q2 2022

Sep 21, 2022

BUY
$278.73 - $327.27 $106,196 - $124,689
381 New
381 $124,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Coston, Mc Isaac & Partners Portfolio

Follow Coston, Mc Isaac & Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coston, Mc Isaac & Partners, based on Form 13F filings with the SEC.

News

Stay updated on Coston, Mc Isaac & Partners with notifications on news.